Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach

American Journal of Pathology

Volumn 156, Issue 4, 2000, Pages 1381-1393

  Albini, Adriana ^a   Marchisone, Chiara ^b   Del Grosso, Federica ^b   Benelli, Roberto ^a   Masiello, Luciana ^a   Tacchetti, Carlo ^c   Bono, Maria ^c   Ferrantini, Maria ^d   Rozera, Carmela ^d   Truini, Mauro ^e   Belardelli, Filippo ^d   Santi, Leonardo ^a,b   Noonan, Douglas M ^a  

^a Tumor Progression Section   (Italy)

^b CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; COMPLEMENTARY DNA; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL; TUMOR BLOOD FLOW; TUMOR GROWTH;

EID: 0033848253     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65007-9     Document Type: Article

References (42)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
3. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
4. Cytokine therapeutics: Lessons from interferon alpha
5. The neglected role of type I interferon in the T-cell response: Implications for its clinical use
6. Human recombinant interferons-beta and -gamma decrease gelatinase production and invasion by human KG-2 renalcarcinoma cells
7. Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas
8. Interferons inhibit chemotaxis of transformed cells and their invasion of a reconstituted basement membrane
9. Beta interferon inhibits HIV-1 Tat induced angiogenesis; synergism with 13-cis retinoic acid
10. Gene therapy strategies for tumor antiangiogenesis
11. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
12. Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: A pilot study in humans
13. Basement membranes complexes with biological activity
14. Permanent cell line expressing human factor VIII-related antigen established by hybridization
15. The b-core fragment of human chorionic gonadotropin (hCG) inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line
16. Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis
17. Construction and use of a safe and efficient amphotropic packaging cell line
18. Improved retroviral vectors for gene transfer and expression
19. Interferon (IFN)-β gene transfer into TS/A adenocarcinoma cells and comparison with IFN-α: Differential effects on tumor-igenicity and host response
20. Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons
21. Tumor and endothelial cell invasion of basement membranes
22. A rapid in vitro assay for quantitating the invasive potential of tumor cells
23. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibro-blast growth factor
24. Angiogenic potential in vivo by Kaposi sarcoma cell-free supernatants and HIV1-tat product: Inhibition of KS-like lesions by TIMP-2
25. HIV-1 Tat induced angiogenesis is mediated by activation of the flk-1/KDR tyrosine kinase receptor on vascular endothelial cells
26. Tumor necrosis factor-α regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells
27. Inhibition of angiogenesis
28. Induction of apoptosis in human dermal microvascular endothelial cells and infantile hemangiomas by interferon-alpha
29. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration
30. Endogenous IFN-alpha beta suppresses colony-stimulating factor (CSF)-1-stimulated macrophage DNA synthesis and mediates inhibitory effects of lipopolysaccharide and TNF-alpha
31. Selective interferon-alpha/beta effects on platelet-derived growth factor-stimulated processes in quiescent BALB/c-3T3 fibroblasts
32. Interferons inhibit EGF-stimulated cell growth and reduce EGF binding in human breast cancer cells
33. The combination of anti-angiogenic agents to inhibit primary tumor growth and metastasis
34. Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis
35. Inhibition of angiogenesis by interferons: Effects on tumor- and lymphocyte-induced vascular responses
36. Suppression of gelatinase production with decreased invasiveness of choriocarcinoma cells by human recombinant interferon beta
37. IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells
38. The induction of in vivo proliferation of long-lived CD44hi CD8+ T cells after the injection of tumor cells expressing IFN-alpha 1 into syngeneic mice
39. The production of cytokines by polymorphonuclear neutrophils